CAPE CANAVERAL, FLA.--(BUSINESS WIRE)--
SAFE-BioPharma Association, LLC today announced Axiad ID Cloud, a cloud-based trusted identity platform from its newest vendor partner, Axiad IDS, has been certified compliant with the SAFE-BioPharma® global digital identity and signature standards.
Axiad IDS is a leading provider of authentication and trusted identity solutions. The company’s Axiad ID Cloud makes it simple for biopharmaceutical and healthcare companies to manage SAFE-BioPharma compliant identity credentials.
Specifically, Axiad ID Cloud provides organizations with a frictionless user experience from the creation and issuance of secure SAFE-BioPharma credentials to the use and full lifecycle management of the credentials.
“We are excited to team with SAFE-BioPharma to make it easier for our customers to acquire and manage compliant identity credentials via Axiad ID Cloud,” said Audebert. “Together we are helping biopharmaceutical and healthcare organizations protect patient privacy, improve health transaction security and fortify patient safety.”
Axiad IDS’ multi-factor authentication and identity management services joined together with the SAFE-BioPharma standards, enable management of access to electronic medical records, clinical portals, and application of digital signatures to electronic documents, including those in the cloud. This can be easily implemented using interoperable cyber-identities issued through the Axiad ID Cloud. With Axiad ID Cloud, organizations can easily issue and manage smart cards and tokens with PKI certificates for authentication, signature, and encryption –- anytime, anywhere.
“Axiad ID Cloud leverages the convenience of the cloud while gaining efficiencies in management of SAFE-BioPharma compliant credentials. We look forward to Axiad IDS’ use of the standard in developing innovative solutions for that improve the user experience and security across the healthcare industry,” said Matt King, Director of SAFE-BioPharma Association, LLC.
Axiad IDS is a Trusted Identity solutions provider for enterprise, government, and financial organizations. Axiad IDS was founded by industry experts with extensive backgrounds in developing, deploying, and managing identity and access management solutions. These experts have experienced first-hand the challenges associated with implementing and managing mission-critical identity systems, and are experienced in overcoming those challenges, enabling their success. Axiad IDS is driven by its customers’ business needs, addressing business objectives with innovative and cost-effective solutions. Axiad IDS was founded in 2010 and is headquartered in Santa Clara, CA.
About SAFE-BioPharma Association, LLC
As part of the National Health Information Sharing and Analysis Center (NH-ISAC), SAFE-BioPharma Association, LLC provides global, high-assurance identity trust for cyber-transactions in the biopharmaceutical and healthcare industries.
The SAFE-BioPharma® digital identity and signature standards were crafted to mitigate risk associated with electronic transactions by protecting intellectual property and patient data using secure, enforceable, and regulatory compliant mechanisms.
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Use of this trademark requires approval from SAFE-BioPharma Association.
NH-ISAC is a non-profit, member-driven organization offering healthcare stakeholders a trusted community and forum for sharing cyber and physical threat indicators, vulnerabilities, best practices and mitigation strategies.
Copyright Business Wire 2018